Multiple motor regions of the brain are underactive during lower limb movements in Parkinson's patients, according to a study.

Published Date: 26 Apr 2023

Parkinson's disease is a prevalent neurodegenerative condition that impairs movement. A person's gait and balance are eventually affected by the disease, which frequently starts with minor hand tremors.

Read Full News

Latest News

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral Palsy Linked to Gaps in Gynecologic Care

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

Borderline Personality: Evidence Has Evolved. Care Hasn’t

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

New Stroke Rehab Guideline Calls for Earlier, Broader Care

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

Exercise May Prevent Memory Loss From Sleep Restriction

A 30-minute moderate-intensity exercise session before bedtime may protect long-term memory from cognitive impairment related to restricted sleep, a trial shows.

Duchenne Drug Gets Three-month FDA Extension After New Data Submission

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration had extended the review period for ⁠its experimental cell therapy for Duchenne muscular dystrophy...

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Todays Updates

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Latest News

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

A 30-minute moderate-intensity exercise session before bedtime may protect long-term memory from cognitive impairment related to restricted sleep, a trial shows.

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration had extended the review period for ⁠its experimental cell therapy for Duchenne muscular dystrophy...

News All Time

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

Long-term study looks at what happened when sugar was scarce

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

FDA Committee Votes Down Duchenne Drug

Agency staff and drug developer disagree on endpoints

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

Health news and commentary gathered by MedPage Today staff

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

News and commentary from the world of neurology and neuroscience

FDA Approves First-in-Class Narcolepsy Drug

Oveporexton treats more than symptoms, restores orexin signaling

Pet Hamsters Linked to Rare Brain Disorder

Exposure was associated with autoimmune cerebellar ataxia in a hospital case-control study

Trump Issues Controversial Order on Vaccines, Suggests Autism Link

Order calls for MMR vaccine to be split up, given at separate medical appointments

Recommended News For You

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

Radiotherapy after mastectomy can be avoided, study finds

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

Researchers publish action plan to address appendiceal cancer enigmas

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

Some low-grade prostate cancers carry higher risks than biopsy suggests

Recommended Articles For You

Metabolic Vulnerabilities in Solid Tumor Progression 

The Danger of Methemoglobinemia and How to Prevent It  

Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers 

Metabolic Heterogeneity and Tumor Persistence: Mechanisms, Clinical Implications, and Emerging Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

2.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

3.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

4.

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

5.

How AI will transform mental health support for patients with breast cancer

1.

Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends

2.

Evolutionary Intelligence for Oncology Research Optimization

3.

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key

4.

Clinical Pharmacology of Iron Homeostasis Regulatory Therapeutics

5.

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

3.

Managing Fatigue During Cancer Treatment

4.

Recognizing General Warning Signs of Cancer

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot